These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 9745157)
1. A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient. Jongerius JM; van der Poel CL; van Leeuwen EF Vox Sang; 1998; 75(1):66-9. PubMed ID: 9745157 [TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP; Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [TBL] [Abstract][Full Text] [Related]
4. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L; Strong DM; Tegtmeier G; Stramer S Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [TBL] [Abstract][Full Text] [Related]
5. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
6. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154 [TBL] [Abstract][Full Text] [Related]
7. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [TBL] [Abstract][Full Text] [Related]
8. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H; Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150 [TBL] [Abstract][Full Text] [Related]
9. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. Almeida RP; Cardoso DD J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475 [TBL] [Abstract][Full Text] [Related]
10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
11. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E; Grabarczyk P; Liszewski G; Mikulska M; Allain JP; Letowska M; Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474 [TBL] [Abstract][Full Text] [Related]
12. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
14. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking]. Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609 [TBL] [Abstract][Full Text] [Related]
17. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases. Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J; Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347 [TBL] [Abstract][Full Text] [Related]
18. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Dreier J; Kröger M; Diekmann J; Götting C; Kleesiek K Transfus Med; 2004 Apr; 14(2):97-103. PubMed ID: 15113374 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]